1
|
Antoni S, Soerjomataram I, Møller B, Bray
F and Ferlay J: An assessment of GLOBOCAN methods for deriving
national estimates of cancer incidence. Bull World Health Organ.
94:174–184. 2016. View Article : Google Scholar : PubMed/NCBI
|
2
|
Elkum N, Dermime S, Ajarim D, Al-Zahrani
A, Alsayed A, Tulbah A, Al Malik O, Alshabanah M, Ezzat A and
Al-Tweigeri T: Being 40 or younger is an independent risk factor
for relapse in operable breast cancer patients: The Saudi Arabia
experience. BMC Cancer. 7:2222007. View Article : Google Scholar : PubMed/NCBI
|
3
|
Fredholm H, Eaker S, Frisell J, Holmberg
L, Fredriksson I and Lindman H: Breast cancer in young women: Poor
survival despite intensive treatment. PLoS One. 4:e76952009.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Anders CK, Johnson R, Litton J, Phillips M
and Bleyer A: Breast cancer before age 40 years. Semin Oncol.
36:237–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Musolino A, Bella MA, Bortesi B, Michiara
M, Naldi N, Zanelli P, Capelletti M, Pezzuolo D, Camisa R, Savi M,
et al: BRCA mutations, molecular markers, and clinical variables in
early-onset breast cancer: A population-based study. Breast.
16:280–292. 2007. View Article : Google Scholar : PubMed/NCBI
|
6
|
Klauber-DeMore N: Tumor biology of breast
cancer in young women. Breast Dis. 23:9–15. 2005. View Article : Google Scholar : PubMed/NCBI
|
7
|
Smigal C, Jemal A, Ward E, Cokkinides V,
Smith R, Howe HL and Thun M: Trends in breast cancer by race and
ethnicity: Update 2006. CA Cancer J Clin. 56:168–183. 2006.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Samphao S, Wheeler AJ, Rafferty E,
Michaelson JS, Specht MC, Gadd MA, Hughes KS and Smith BL:
Diagnosis of breast cancer in women age 40 and younger: Delays in
diagnosis result from underuse of genetic testing and breast
imaging. Am J Surg. 198:538–543. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Mauad EC, Nicolau SM, Moreira LF, Haikel
RL Jr, Longatto-Filho A and Baracat EC: Adherence to cervical and
breast cancer programs is crucial to improving screening
performance. Rural Remote Health. 9:12412009.PubMed/NCBI
|
10
|
Milani V, Goldman SM, Finguerman F,
Pinotti M, Ribeiro CS, Abdalla N and Szejnfeld J: Presumed
prevalence analysis on suspected and highly suspected breast cancer
lesions in São Paulo using BIRADS criteria. Sao Paulo Med J.
125:210–214. 2007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Tarone RE: Breast cancer trends among
young women in the United States. Epidemiology. 17:588–590. 2006.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Freitas-Junior R, Freitas NM, Curado MP,
Martins E, Moreira MA and e Silva CM: Variations in breast cancer
incidence per decade of life (Goiânia, GO, Brazil): 16-year
analysis. Cancer Causes Control. 19:681–687. 2008. View Article : Google Scholar : PubMed/NCBI
|
13
|
Dutra MC, Rezende MA, de Andrade VP,
Soares FA, Ribeiro MV, de Paula EC and Gobbi H: Immunophenotype and
evolution of breast carcinomas: A comparison between very young and
postmenopausal women. Rev Bras Ginecol Obstet. 31:54–60. 2009.(In
Portuguese). PubMed/NCBI
|
14
|
Gnerlich JL, Deshpande AD, Jeffe DB, Sweet
A, White N and Margenthaler JA: Elevated breast cancer mortality in
women younger than age 40 years compared with older women is
attributed to poorer survival in early-stage disease. J Am Coll
Surg. 208:341–347. 2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Yancik R, Havlik RJ, Wesley MN, Ries L,
Long S, Rossi WK and Edwards BK: Cancer and comorbidity in older
patients: A descriptive profile. Ann Epidemiol. 6:399–412. 1996.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Allred DC, Harvey JM, Berardo M and Clark
GM: Prognostic and predictive factors in breast cancer by
immunohistochemical analysis. Mod Pathol. 11:155–168.
1998.PubMed/NCBI
|
17
|
Greene FL, Page DL, Fleming ID, Fritz AG,
Balch CM, Haller DG and Morrow M: AJCC Cancer Staging Manual. 6th.
Springer-Verlag; New York: pp. 227–229. 2002
|
18
|
Rapiti E, Fioretta G, Verkooijen HM,
Vlastos G, Schäfer P, Sappino AP, Kurtz J, Neyroud-Caspar I and
Bouchardy C: Survival of young and older breast cancer patients in
Geneva from 1990 to 2001. Eur J Cancer. 41:1446–1452. 2005.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Varga D, Koenig J, Kuhr K, Strunz K, Geyer
V, Kurzeder C, Atassi Z, Blettner M, Kreienberg R and Woeckel A:
Comparison of early onset breast cancer patients to older
premenopausal breast cancer patients. Arch Gynecol Obstet.
282:427–432. 2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Clagnan WS, Andrade JM, Carrara HH, Tiezzi
DG, Reis FJ, Marana HR and Abrão RA: Age as an independent
prognostic factor in breast cancer. Rev Bras Ginecol Obstet.
30:67–74. 2008.(In Portuguese). View Article : Google Scholar : PubMed/NCBI
|
21
|
Maggard MA, O'Connell JB, Lane KE, Liu JH,
Etzioni DA and Ko CY: Do young breast cancer patients have worse
outcomes? J Surg Res. 113:109–113. 2003. View Article : Google Scholar : PubMed/NCBI
|
22
|
Coleman MP, Quaresma M, Berrino F, Lutz
JM, De Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G,
Hakulinen T, et al: Cancer survival in five continents: A worldwide
population-based study (CONCORD). Lancet Oncol. 9:730–756. 2008.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Perry N, Broeders M, de Wolf C, Törnberg
S, Holland R and von Karsa L: European guidelines for quality
assurance in breast cancer screening and diagnosis. Fourth
edition-summary document. Ann Oncol. 19:614–622. 2008. View Article : Google Scholar : PubMed/NCBI
|
24
|
Chan A, Pintilie M, Vallis K, Girourd C
and Goss P: Breast cancer in women <or=35 years: Review of 1002
cases from a single institution. Ann Oncol. 11:1255–1262. 2000.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Fowble BL, Schultz DJ, Overmoyer B, Solin
LJ, Fox K, Jardines L, Orel S and Glick JH: The influence of young
age on outcome in early stage breast cancer. Int J Radiat Oncol
Biol Phys. 30:23–33. 1994. View Article : Google Scholar : PubMed/NCBI
|
26
|
Yildirim E, Dalgic T and Berberoğlu U:
Prognostic significance of young age in breast cancer. J Surg
Oncol. 74:267–272. 2000. View Article : Google Scholar : PubMed/NCBI
|
27
|
Goldstein NS, Vicini FA, Kestin LL and
Thomas M: Differences in the pathologic features of ductal
carcinoma in situ of the breast based on patient age. Cancer.
88:2553–2560. 2000. View Article : Google Scholar : PubMed/NCBI
|
28
|
Zabicki K, Colbert JA, Dominguez FJ, Gadd
MA, Hughes KS, Jones JL, Specht MC, Michaelson JS and Smith BL:
Breast cancer diagnosis in women < or=40 versus 50 to 60 years:
Increasing size and stage disparity compared with older women over
time. Ann Surg Oncol. 13:1072–1077. 2006. View Article : Google Scholar : PubMed/NCBI
|
29
|
Berry DA, Cronin KA, Plevritis SK, Fryback
DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD and
Feuer EJ: Cancer Intervention and Surveillance Modeling Network
(CISNET) Collaborators: Effect of screening and adjuvant therapy on
mortality from breast cancer. N Engl J Med. 353:1784–1792. 2005.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Tabar L, Yen MF, Vitak B, Chen HH, Smith
RA and Duffy SW: Mammography service screening and mortality in
breast cancer patients: 20-year follow-up before and after
introduction of screening. Lancet. 361:1405–1410. 2003. View Article : Google Scholar : PubMed/NCBI
|
31
|
Gomes MC, Costa MM, Borojevic R, Monteiro
AN, Vieira R, Koifman S, Koifman RJ, Li S, Royer R, Zhang S and
Narod SA: Prevalence of BRCA1 and BRCA2 mutations in breast cancer
patients from Brazil. Breast Cancer Res Treat. 103:349–353. 2007.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Risendal B, Hines LM, Sweeney C, Slattery
ML, Giuliano AR, Baumgartner KB, Curtin K and Byers TE: Family
history and age at onset of breast cancer in Hispanic and
non-Hispanic white women. Cancer Causes Control. 19:1349–1355.
2008. View Article : Google Scholar : PubMed/NCBI
|
33
|
Bharat A, Aft RL, Gao F and Margenthaler
JA: Patient and tumor characteristics associated with increased
mortality in young women (<or=40 years) with breast cancer. J
Surg Oncol. 100:248–251. 2009. View Article : Google Scholar : PubMed/NCBI
|
34
|
Siegelmann-Danieli N, Khandelwal V, Wood
GC, Mainali R, Prichard J, Murphy TJ, Evans JF, Yumen O and Bernath
AM: Breast cancer in elderly women: Outcome as affected by age,
tumor features, comorbidities, and treatment approach. Clin Breast
Cancer. 7:59–66. 2006. View Article : Google Scholar : PubMed/NCBI
|
35
|
Colleoni M, Rotmensz N, Robertson C,
Orlando L, Viale G, Renne G, Luini A, Veronesi P, Intra M, Orecchia
R, et al: Very young women (<35 years) with operable breast
cancer: Features of disease at presentation. Ann Oncol. 13:273–279.
2002. View Article : Google Scholar : PubMed/NCBI
|
36
|
El Saghir NS, Seoud M, Khalil MK,
Charafeddine M, Salem ZK, Geara FB and Shamseddine AI: Effects of
young age at presentation on survival in breast cancer. BMC Cancer.
6:1942006. View Article : Google Scholar : PubMed/NCBI
|
37
|
Parise CA, Bauer KR, Brown MM and Caggiano
V: Breast cancer subtypes as defined by the estrogen receptor (ER),
progesterone receptor (PR), and the human epidermal growth factor
receptor 2 (HER2) among women with invasive breast cancer in
California, 1999–2004. Breast J. 15:593–602. 2009. View Article : Google Scholar : PubMed/NCBI
|
38
|
Han W, Kim SW, Park IA, Kang D, Youn YK,
Oh SK, Choe KJ and Noh DY: Young age: An independent risk factor
for disease-free survival in women with operable breast cancer. BMC
Cancer. 4:822004. View Article : Google Scholar : PubMed/NCBI
|
39
|
Jmor S, Al-Sayer H, Heys SD, Payne S,
Miller I, Ah-See A, Hutcheon A and Eremin O: Breast cancer in women
aged 35 and under: Prognosis and survival. J R Coll Surg Edinb.
47:693–699. 2002.PubMed/NCBI
|
40
|
Aebi S, Gelber S, Castiglione-Gertsch M,
Gelber RD, Collins J, Thürlimann B, Rudenstam CM, Lindtner J,
Crivellari D, Cortes-Funes H, et al: Is chemotherapy alone adequate
for young women with oestrogen-receptor-positive breast cancer?
Lancet. 355:1869–1874. 2000. View Article : Google Scholar : PubMed/NCBI
|
41
|
Fernandopulle SM, Cher-Siangang P and Tan
PH: Breast carcinoma in women 35 years and younger: A pathological
study. Pathology. 38:219–222. 2006. View Article : Google Scholar : PubMed/NCBI
|
42
|
Gajdos C, Tartter PI, Bleiweiss IJ, Bodian
C and Brower ST: Stage 0 to stage III breast cancer in young women.
J Am Coll Surg. 190:523–529. 2000. View Article : Google Scholar : PubMed/NCBI
|
43
|
Sidoni A, Cavaliere A, Bellezza G,
Scheibel M and Bucciarelli E: Breast cancer in young women:
Clinicopathological features and biological specificity. Breast.
12:247–250. 2003. View Article : Google Scholar : PubMed/NCBI
|